Enfermedad pulmonar intersticial linfocítica granulomatosa: descripción de una serie de 9 casos

Ruiz-Alcaraz, Sandra; Gayá García-Manso, Ignacio; Marco-De La Calle, Francisco Manuel; García-Mullor, María del Mar; López-Brull, Helena; García-Sevila, Raquel.
Med. clín (Ed. impr.) ; 156(7): 344-348, abril 2021. tab, ilus
Artículo en Español | IBECS (España) | ID: ibc-208492

Documentos relacionados

  1. Rituximab Monotherapy Is Effective as First-Line Treatment for Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in CVID Patients.
  2. Glimpses into treating GLILD.
  3. Raised Serum Markers of T Cell Activation and Exhaustion in Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency.
  4. Granulomatous Lymphocytic Interstitial Lung Disease in a Spectrum of Pediatric Primary Immunodeficiencies.
  5. Common and Uncommon CT Findings in CVID-Related GL-ILD: Correlations with Clinical Parameters, Therapeutic Decisions and Potential Implications in the Differential Diagnosis.
  6. Predictors of granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency: Methodological issues.
  7. Author's response.
  8. [Granulomatous lymphocytic interstitial lung disease: description of a series of 9 cases].
  9. Navigating the management complexity in long-term asymptomatic immunodeficiency.
  10. Allogeneic Hematopoietic Cell Transplantation Ameliorated Asymptomatic Granulomatous and Lymphocytic Interstitial Lung Disease in a Patient With XIAP Deficiency.